Virtual Medicinal Product (VMP) - Amphotericin B (lipid formulation) 100mg/20ml suspension for infusion vials

Navigation

Name Details

Name Start Date End Date
Current Name Amphotericin B (lipid formulation) 100mg/20ml suspension for infusion vials 28-07-2009
Previous Name Amphotericin B (lipid formulation) 100mg/20ml suspension for injection vials 11-09-2007 27-07-2009
Previous Abbreviated Name Amphotericin B (lipid formulation) 100mg/20ml inf vials 28-07-2009 23-06-2016

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
20.0
UDFS UOM
ml
Unit Dose UOM
vial

Summary

Invalid
Prescribing Status
Caution - AMP level prescribing advised
Controlled Drug Category
No Controlled Drug Status
Route
Intravenous
Form
Obsolete - Suspension for infusion
Ontology Form/Route
suspensioninfusion.intravenous
Name Basis
rINN - Recommended International Non-proprietary

Codes

BNF Codes
  • BNF code 05020000
SNOMED Codes
Code Start Date End Date
324654000 18-08-2004

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Amphotericin B phospholipid complex Based on Base Substance Amphotericin B 5 mg 1 ml

Parent Products

  • VTM
    No Parent VTM
    • VMP
      (Current) Amphotericin B (lipid formulation) 1...
      • AMP
        No AMP's

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
10 vial